tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
toxicity↝, tumCV↓, ROS↑, p38↑, NRF2↓, NF-kB↝, DNAdam↑, Apoptosis↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
THP1 |
|
|
|
Apoptosis↑, Casp7↑, PARP1↑, Bcl-2↓, Myc↓, CHOP↑, P21↑, p62↑, TumCCA↑, TXNIP↑, ROS↑, *antiOx↑, *Inflam↓, *neuroP↑, AntiCan↑, TumCP↓, angioG↓, TumMeta↓, VEGF↓, MMPs↓, tumCV↓, DNAdam↑, CHOP↑, cMyc↓, BioAv↓, Half-Life↓, BioAv↑,
tumCV↓, TumCCA↑, P21↑, p27↑, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Cyt‑c↑, cl‑PARP↓, DNAdam↑, Casp3↑, FASN↓, Casp8↑,
| - |
in-vitro, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
SK-HEP-1 |
|
|
|
tumCV↓, TumCCA↑, Ferroptosis↑, lipid-P↑, HO-1↑, GPx4∅,
selectivity↑, LC3I↑, LC3II↑, Beclin-1↑, ROS↑, tumCV↓, Dose↝, TumAuto↑,
| - |
in-vitro, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
Jurkat |
|
|
|
- |
in-vitro, |
AML, |
HL-60 |
|
|
|
tumCV↓, Casp3↑, Casp8↑, Casp9↑, P53↑, BAX↑, Fas↑, FasL↑, MAPK↑, NRF2↓, GSH↓,
tumCV↓, Apoptosis↑, ROS↑, eff↓, DR4↑, DR5↑, TRAIL↑,
Prx↓, AQPs↓, NOX↓, tumCV↓, AntiCan↑, cardioP↑, neuroP↑, Inflam↓, chemoPv↑, angioG↓, TumMeta↓, selectivity↑, ROS↓,
eff↑, tumCV↓, TumCCA↑, ROS↑, MMP↓, eff↑, TumVol↓, eff↑, Ki-67↓,
tumCV↓, selectivity↑, Apoptosis↑, eff↑, ChemoSen↑,
Showing Research Papers: 1 to 10 of 10
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 10
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4∅, 1, GSH↓, 1, HO-1↑, 1, lipid-P↑, 1, NRF2↓, 2, Prx↓, 1, ROS↓, 1, ROS↑, 5,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, FASN↓, 1,
Cell Death ⓘ
Apoptosis↑, 4, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp3↑, 2, Casp7↑, 1, Casp8↑, 2, Casp9↑, 1, Cyt‑c↑, 1, DR4↑, 1, DR5↑, 1, Fas↑, 1, FasL↑, 1, Ferroptosis↑, 1, MAPK↑, 1, Myc↓, 1, p27↑, 1, p38↑, 1, TRAIL↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 10,
Protein Folding & ER Stress ⓘ
CHOP↑, 2,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3I↑, 1, LC3II↑, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 3, P53↑, 1, cl‑PARP↓, 1, PARP1↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, cycE/CCNE↓, 1, P21↑, 2, TumCCA↑, 4,
Migration ⓘ
Ki-67↓, 1, MMPs↓, 1, TumCP↓, 1, TumMeta↓, 2, TXNIP↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, VEGF↓, 1,
Barriers & Transport ⓘ
AQPs↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, NF-kB↝, 1,
Cellular Microenvironment ⓘ
NOX↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 1, Dose↝, 1, eff↓, 1, eff↑, 4, Half-Life↓, 1, selectivity↑, 3,
Clinical Biomarkers ⓘ
Ki-67↓, 1, Myc↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 2, cardioP↑, 1, chemoPv↑, 1, neuroP↑, 1, toxicity↝, 1, TumVol↓, 1,
Total Targets: 73
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Functional Outcomes ⓘ
neuroP↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page